|
Current Board Members
Vaccine Industry – Industrialized Country
Currently represented on the GAVI Board by
Merck Vaccines
Board Member: Dr Adel A. F. Mahmoud, President Term of Office: April 2005 to May 2008
[ FIIM IFPMA logo ]The International Federation of Pharmaceutical Manufacturers Associations (
IFPMA ) provides the forum for representation of the industrialized country vaccine industry in GAVI. The IFPMA represents over 55 national industry associations from both developed and developing countries. Companies in membership of the IFPMA are the major global research-based pharmaceutical and vaccine companies.
The vaccine-producing members of the IFPMA have a long-standing legacy of working with international public health agencies to ensure the enhancement of health for children globally, through immunization. Through the alliance, member partners address ways to accelerate the development and introduction of new vaccines specifically needed by developing countries.
The vaccine industry members of the IFPMA, in cooperation with their GAVI partners, work to ensure accessibility to vaccines for all the world’s children with a particular focus on the poorest people and countries.
The specific vaccine industry partners involved in GAVI are those that produce the greatest share of the global vaccine supply. They are:
-
Wyeth Vaccines
-
Chiron Vaccines
-
Berna Biotech (representing smaller vaccine producers)
-
Glaxo SmithKline
-
Merck & Co., Inc.
-
Aventis Pasteur
Former Board Members
Chiron Vaccines
Board Member: Mr. John Lambert Term of Office: January 2004 to March 2005
Wyeth-Ayerst Global Pharmaceuticals
Board Member: Mr. Geno Germano, Executive Vice President and General Manager, Wyeth Vaccines Term of Office: January 2002 to December 2003
|
|
|
|
GAVI Partners
The Bill & Melinda Gates Foundation
WHO
UNICEF
The World Bank Group
Developing Country Governments
Nongovernmental Organization
Industrialized Country Governments
Research Institutes
Vaccine Industry-Industrialized Country
Technical Health Institutes
Vaccine Industry-Developing Country
|
|